FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Regnum Corp. Stock AnalysisComprehensive stock analysis for Regnum Corp. (RGMP) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisRGMP
RGMP
Regnum Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RGMP
Home🔹Stocks🔹Regnum Corp.

Regnum Corp.

RGMP•OTC

Regnum Corp.

RGMP•OTC
Market cap
$2.29K
Sentiment

Your view on RGMP

Mkt Cap
$2.29K
Sentiment
Your view
RGMP
Regnum Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RGMP
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Regnum Corp.

Industry
Biotechnology
Sector
Healthcare
CEO
Robert J. Stubblefield
Headquarters
600 Third Avenue, New York City, NY, US
Industry
Biotechnology
Sector
Healthcare
CEO
Robert J. Stubblefield
Headquarters
600 Third Avenue, New York City, NY, US
Description

Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody C—C chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company is based in New York, New York. Regnum Corp. is a subsidiary of Phoenixus AG.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News